Use of Biomarkers to Objectively Evaluate Pain in Critically Ill Children: A Scoping Review

Eleni Tamvaki1, Margarita Giannakopoulou2, Evangelos Bozas3

  • 1Eleni Tamvaki is a registered nurse in pediatric intensive care and a clinical researcher in inherited and rare diseases, Great Ormond Street Hospital for Children, London, England.

Critical Care Nurse
|January 31, 2024
PubMed

Insights

Researchers identified endogenous biomarkers in saliva, blood, and other fluids that correlate with pain in children. Further studies are needed to confirm their use for objective pain assessment in critically ill youth.

Area of Science:

  • Biomedical Science
  • Pediatric Critical Care
  • Pain Management

Background:

  • Objective pain evaluation in children is challenging.
  • Recent research focuses on identifying reliable pain biomarkers.
  • Endogenous biomarkers offer potential for objective pain assessment.

Purpose of the Study:

  • To synthesize and critically analyze studies on endogenous biomarkers and pain.
  • To identify suitable biomarkers for objective pain evaluation in critically ill children.

Main Methods:

  • Systematic literature search of PubMed, Scopus, and Ovid.
  • Quality assessment using critical appraisal tools and STROBE checklist.
  • Coding of articles for methods and findings.

Main Results:

  • Biomarkers were detected in saliva, blood, cerebrospinal fluid, and gingival crevicular fluid.
  • Cytokines, peptides, and hormones showed associations with pain, stress, and inflammation.
  • Most studies (64%) utilized enzyme-linked immunosorbent assays.

Conclusions:

  • Various easily obtainable biomarkers are associated with pain in children.
  • Further observational studies are recommended for pain assessment in critically ill children.
  • Biomarkers show promise for objective pain evaluation in pediatric critical care settings.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
158
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
623